Order delays due to the continued impact of COVID-19

THYMOSIN ALPHA 1

STUDIES & RESEARCH

Our Medical Team is constantly engaging in research and development, and keeping up to date with the latest medical papers and clinical trials to inform our patients about the peptides we supply. Access the latest clinical studies relating to Thymosin Alpha 1 below.

Thymosin Alpha-1 is taken through subcutaneous injection and is a powerful modulator of immunity and inflammation. This 28 amino acid Peptide has been widely studied as an immunity booster in conjunction with flu vaccinations. Thymosin Alpha-1 works to enhance T cell function and antibody responses.

Learn More

May 2020

September 2016

May 2016

Go to Top